1.71 -0.03 (-1.73%)
LXRX
| Trade LXRX now with |
|
Stock Details
Last Trade:1.71 Change:-0.03 (-1.73%) Prev Close:1.74 Open: 1.73 Days Range:1.68 – 1.73 52 Week Range: 0.81 - 2.05 Volume:439891 P/E: N/AEPS:-0.32
View AllRecent Alerts 02/09/12
Recent Alert on 01/10/12 at 9:02am
Pre-Open Movers 1/10: (REGN) (ELX) (CRUS) Higher; (WBMD) (LIZ) (TIF) Lower (more...)
Pre-Open Movers 1/10: (REGN) (ELX) (CRUS) Higher; (WBMD) (LIZ) (TIF) Lower (more...)
Below are stocks making major moves in pre-open trading Tuesday: HIGHER: Regeneron Pharmaceuticals (Nasdaq: REGN) 14% HIGHER; strong Eylea sales Emulex (NYSE: ELX) 13% HIGHER; raises Q2 outlook Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) 12%... Read More
Recent Alert on 01/09/12 at 7:03pm
After-Hours Movers 01/09: (LXRX) (ELX) (CRUS) Higher; (LIZ) (WDFC) (SMSC) (TRNO) (JNPR) Lower
After-Hours Movers 01/09: (LXRX) (ELX) (CRUS) Higher; (LIZ) (WDFC) (SMSC) (TRNO) (JNPR) Lower
Recent Alert on 01/09/12 at 4:41pm
Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4
Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4
Recent Alert on 01/09/12 at 4:41pm
Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4
Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4
Recent Alert on 01/06/12 at 10:13am
Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); 2012 Preview: Several Key Clinical Milestones Anticipated
Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); 2012 Preview: Several Key Clinical Milestones Anticipated
View AllRecent Press Releases
Press Release on 02/07/12 at 6:00pm
Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 01/11/12 at 8:42pm
Lexicon Pharmaceuticals' CEO Presents at JP Morgan Healthcare Conference (Transcript)
Lexicon Pharmaceuticals' CEO Presents at JP Morgan Healthcare Conference (Transcript)